65
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Stochastic Loss of Silencing of the Imprinted Ndn/NDN Allele, in a Mouse Model and Humans with Prader-Willi Syndrome, Has Functional Consequences

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Genomic imprinting is a process that causes genes to be expressed from one allele only according to parental origin, the other allele being silent. Diseases can arise when the normally active alleles are not expressed. In this context, low level of expression of the normally silent alleles has been considered as genetic noise although such expression has never been further studied. Prader-Willi Syndrome (PWS) is a neurodevelopmental disease involving imprinted genes, including NDN, which are only expressed from the paternally inherited allele, with the maternally inherited allele silent. We present the first in-depth study of the low expression of a normally silent imprinted allele, in pathological context. Using a variety of qualitative and quantitative approaches and comparing wild-type, heterozygous and homozygous mice deleted for Ndn, we show that, in absence of the paternal Ndn allele, the maternal Ndn allele is expressed at an extremely low level with a high degree of non-genetic heterogeneity. The level of this expression is sex-dependent and shows transgenerational epigenetic inheritance. In about 50% of mutant mice, this expression reduces birth lethality and severity of the breathing deficiency, correlated with a reduction in the loss of serotonergic neurons. In wild-type brains, the maternal Ndn allele is never expressed. However, using several mouse models, we reveal a competition between non-imprinted Ndn promoters which results in monoallelic (paternal or maternal) Ndn expression, suggesting that Ndn allelic exclusion occurs in the absence of imprinting regulation. Importantly, specific expression of the maternal NDN allele is also detected in post-mortem brain samples of PWS individuals. Our data reveal an unexpected epigenetic flexibility of PWS imprinted genes that could be exploited to reactivate the functional but dormant maternal alleles in PWS. Overall our results reveal high non-genetic heterogeneity between genetically identical individuals that might underlie the variability of the phenotype.

          Author Summary

          Genomic imprinting is a process that causes genes to be expressed from only one of the two chromosomes, according to parental origin, the other copy of genes being silent. Prader-Willi Syndrome (PWS) is a neurodevelopmental disease involving imprinted genes, including NDN, which are only expressed from the paternally inherited chromosome, the maternally inherited copy of the gene normally being silent. Here we show that, in absence of the paternal Ndn copy only, the maternal Ndn allele is expressed at an extremely low level with a high degree of heterogeneity. The level of this expression is dependent on both the sex of the offspring and the genotype of the mother. In about 50% of mutant mice, this expression reduces birth mortality and severity of the breathing deficiency, showing a functional role of this low expression. Importantly, specific expression of the maternal NDN allele is also detected in post-mortem brain samples of PWS individuals. Our data reveal an unexpected epigenetic flexibility of PWS imprinted genes that could be exploited to reactivate the functional but dormant maternal alleles in PWS. Overall our results reveal high non-genetic heterogeneity between genetically identical individuals that might contribute to variability in the phenotype.

          Related collections

          Most cited references44

          • Record: found
          • Abstract: found
          • Article: not found

          Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.

          The 5'----3' exonuclease activity of the thermostable enzyme Thermus aquaticus DNA polymerase may be employed in a polymerase chain reaction product detection system to generate a specific detectable signal concomitantly with amplification. An oligonucleotide probe, nonextendable at the 3' end, labeled at the 5' end, and designed to hybridize within the target sequence, is introduced into the polymerase chain reaction assay. Annealing of probe to one of the polymerase chain reaction product strands during the course of amplification generates a substrate suitable for exonuclease activity. During amplification, the 5'----3' exonuclease activity of T. aquaticus DNA polymerase degrades the probe into smaller fragments that can be differentiated from undegraded probe. The assay is sensitive and specific and is a significant improvement over more cumbersome detection methods.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

            K Livak (1999)
            Large-scale screening for known polymorphisms will require techniques with few steps and the ability to automate each of these steps. In this regard, the 5' nuclease, or TaqMan, PCR assay is especially attractive. A fluorogenic probe, consisting of an oligonucleotide labeled with both a fluorescent reporter dye and a quencher dye, is included in a typical PCR. Amplification of the probe-specific product causes cleavage of the probe, generating an increase in reporter fluorescence. By using different reporter dyes, cleavage of allele-specific probes can be detected in a single PCR. The 5' nuclease assay has been successfully used to discriminate alleles that differ by a single base substitution. Guidelines have been developed so that an assay for any single nucleotide polymorphism (SNP) can be quickly designed and implemented. All assays are performed using a single reaction buffer and single thermocycling protocol. Furthermore, a standard method of analysis has been developed that enables automated genotype determination. Applications of this assay have included typing a number of polymorphisms in human drug metabolism genes.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transient homologous chromosome pairing marks the onset of X inactivation.

              Mammalian X inactivation turns off one female X chromosome to enact dosage compensation between XX and XY individuals. X inactivation is known to be regulated in cis by Xite, Tsix, and Xist, but in principle the two Xs must also be regulated in trans to ensure mutually exclusive silencing. Here, we demonstrate that interchromosomal pairing mediates this communication. Pairing occurs transiently at the onset of X inactivation and is specific to the X-inactivation center. Deleting Xite and Tsix perturbs pairing and counting/choice, whereas their autosomal insertion induces de novo X-autosome pairing. Ectopic X-autosome interactions inhibit endogenous X-X pairing and block the initiation of X-chromosome inactivation. Thus, Tsix and Xite function both in cis and in trans. We propose that Tsix and Xite regulate counting and mutually exclusive choice through X-X pairing.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Genet
                PLoS Genet
                plos
                plosgen
                PLoS Genetics
                Public Library of Science (San Francisco, USA )
                1553-7390
                1553-7404
                September 2013
                September 2013
                5 September 2013
                : 9
                : 9
                : e1003752
                Affiliations
                [1 ]INSERM, Institut de Neurobiologie de la Méditerranée (INMED) U901, Marseille, France
                [2 ]Aix-Marseille Université, INMED UMR901, Marseille, France
                [3 ]Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, The Netherlands
                [4 ]Universitätsmedizin der Johannes Gutenberg-Universität Mainz Institut für Humangenetik, Mainz, Germany
                [5 ]INSERM, U1028, CNRS, UMR5292, Université Claude Bernard Lyon 1, Lyon Neuroscience Center, Villeurbanne, France
                [6 ]Department of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada
                Queensland Institute of Medical Research, Australia
                Author notes

                The authors have declared that no competing interests exist.

                Conceived and designed the experiments: VM LB UZ DS FM. Performed the experiments: AR FS UU VM FW ML BG JB FD SC FJM MB. Analyzed the data: VM UU RW UZ DS LB FM. Contributed reagents/materials/analysis tools: AR FS UU VM FW ML BG JB FD SC FJM. Wrote the paper: KD FM. Provided critical comments for the manuscript: VM UU RW UZ DS LB.

                Article
                PGENETICS-D-13-00927
                10.1371/journal.pgen.1003752
                3764186
                24039599
                f9d0889f-c83d-4371-a58f-70967da46016
                Copyright @ 2013

                This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 8 April 2013
                : 10 July 2013
                Page count
                Pages: 16
                Funding
                This work was supported by INSERM (Institut National de la Santé et de la Recherche Médicale), by ANR (Agence Nationale de la Recherche) grant PRAGEDER, by European community (grant #512136 PWS), by Fondation Jerôme LeJeune, Prader-Willi France and the Canadian Institutes of Health Research (MOP 81290 to RW). AR is a recipient of a Fondation Groupama pour la Santé PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article

                Genetics
                Genetics

                Comments

                Comment on this article